-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HTp3dHD2HWfqwXM46Ug4AlmjQLQ8N/05s+kE+8J/bze3jwGjQFSViLq8SPsRTeLi fj9dZMuN6Fl4MHsm1jhYAw== 0000950110-00-000477.txt : 20000512 0000950110-00-000477.hdr.sgml : 20000512 ACCESSION NUMBER: 0000950110-00-000477 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19981231 FILED AS OF DATE: 20000511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WILSHIRE OIL CO OF TEXAS CENTRAL INDEX KEY: 0000107454 STANDARD INDUSTRIAL CLASSIFICATION: CRUDE PETROLEUM & NATURAL GAS [1311] IRS NUMBER: 840513668 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: SEC FILE NUMBER: 001-04673 FILM NUMBER: 626515 BUSINESS ADDRESS: STREET 1: 921 BERGEN AVE CITY: JERSEY CITY STATE: NJ ZIP: 07306-4204 BUSINESS PHONE: 2014202796 MAIL ADDRESS: STREET 1: 921 BERGEN AVENUE STREET 2: 921 BERGEN AVENUE CITY: JERSEY CITY STATE: NJ ZIP: 07306 10-K/A 1 FORM 10-K/A ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/Al AMENDING ITEMS 10, 11, 12 and 13 (MARK ONE) /X/ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (FEE REQUIRED) For the fiscal year ended DECEMBER 31, 1999 ....................................................... or / / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED) For the transition period from ___________________ to ___________________ Commission file number 1-4673 ------ WILSHIRE OIL COMPANY OF TEXAS ................................................................................ (Exact name of registrant as specified in its charter) DELAWARE 84-0513668 ........ ....................... (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 921 BERGEN AVENUE JERSEY CITY, NEW JERSEY 07306 ....................................... .......... (Address of principal executive offices) (Zip code) Registrant's telephone number, including area code: (201) 420-2796 .............. Securities registered pursuant to Section 12(b) of the Act: NAME OF EACH EXCHANGE TITLE OF EACH CLASS ON WHICH REGISTERED COMMON STOCK, $1 PAR VALUE NEW YORK STOCK EXCHANGE .......................... ....................... Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days. Yes /X/ No / / Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. / / The aggregate market value of the shares of the voting stock held by non-affiliates of the Registrant was approximately $34,666,000 based upon the closing sale price of the stock, which was $4.00 on April 20, 1999. The number of shares of the Registrant's $1 par value common stock outstanding as of May 9, 2000 was 8,185,611. ================================================================================ ITEM 10. DIRECTORS OF THE REGISTRANT The Company's Restated Certificate of Incorporation and By-Laws provide for a seven member Board of Directors divided into three classes of directors serving staggered three-year terms. The term of office of directors in Class II expires at the 2000 Annual Meeting, Class III at the next succeeding Annual Meeting and Class I at the following succeeding Annual Meeting. The information provided below with respect to director nominees and present directors includes (1) name, (2) class, (3) principal occupation and business experience during the past five years, (4) age and (5) the year in which he or she became a director. This information has been furnished by the directors. -2-
YEAR BECAME DIRECTOR OF THE NAME CLASS PRINCIPAL OCCUPATION AND AGE (a) COMPANY .... ..... ................................ ............... Dr. Ira F. Braun ..................... III Director of Neuro Interventional 1981 Radiology, Miami Vascular Institute; Clinical Professor of Radiology, University of Miami; prior thereto at Medical College of Virginia. Age 50. Milton Donnenberg .................... II Formerly President, Milton Donnenberg 1981 Assoc., Realty Management, Carlstadt, N.J. Age 77. S. Wilzig Izak ....................... II Chairman of the Board since 1987 September 20, 1990; Chief Executive Officer since May 1991; Executive Vice President (1987-1990); prior thereto, Senior Vice President. Age 41. Eric J. Schmertz, Esq ................ I Of Counsel to the law firm of Rivkin, 1983 Radler & Kremer since July 1, 1989. Edward F. Carlough Distinguished Professor and formerly Dean, Hofstra University School of Law, Hempstead, N.Y. Age 74. Dr. William J. Schwartz .............. I Chief of Opthamology, Good Samaritan 1983 Hospital, Suffern, N.Y. Age 55. Ernest Wachtel ....................... III President, Ellmax Corp., Builders and 1970 Realty Investors, Elizabeth, N.J. Age 75. W. Martin Willschick ................. III Manager, Treasury Services, City of 1997 Toronto, Canada. Mr. Willschick is Ms. Izak's first cousin. Age 48.
- ------------- (a) No nominee or director is a director of any other company with a class of securites registered pursuant to Section 12 of the Securities Exchange Act of 1934 or subject to the requirements of Section 15(d) of that Act or any company registered as an investment company under the Investment Company Act of 1940. SECTION 16(a) REPORTING Section 16(a) of the Securities Exchange Act of 1934 requires the Company's Directors, executive officers and 10% shareholders to file with the Securities and Exchange Commission certain reports regarding such persons' ownership of the Company's securities. The company is not aware of any reports not filed as required. -3- ITEM 11. EXECUTIVE COMPENSATION The following table sets forth, for the years ended December 31, 1997, 1998 and 1999, the cash compensation paid by the Company and its subsidiaries, as well as certain other compensation paid or accrued by such entities for those years, to or with respect to the Chief Executive Officer of the Company and the only other person who served as an executive officer of the Company during 1999 whose salary and bonus during 1999 exceeded $100,000 (the "Named Officers"), for services rendered in all capacities during such period. SUMMARY COMPENSATION TABLE
LONG TERM ANNUAL COMPENSATION COMPENSATION NAME AND CURRENT ................... ............... ALL OTHER PRINCIPAL POSITION YEAR SALARY BONUS OTHER(A) OPTIONS GRANTED COMPENSATION(B) .................. .... ....... ..... ........ ............... ............... S. Wilzig Izak 1999 $140,000 -- -- -- $ Chairman and CEO 1998 140,000 -- -- -- 1997 140,000 14,000 -- -- Steven A. Gelman 1999 $115,000 -- -- -- $ Senior Vice President 1998 110,000 -- -- -- and Controller 1997 105,000 10,000 -- --
- --------------- (A) During the periods covered, the Named Officers did not receive perquisites (i.e., personal benefits such as country club memberships or use of automobiles). STOCK OPTIONS In June 1995, the Company adopted two new stock-based compensation plans (1995 Stock Option and Incentive Plan and 1995 Non-Employee Director Stock Option Plan) under which up to 450,000 and 150,000 shares of common stock, respectively, are available for grant. Options may no longer be granted under stock option plans approved prior to 1995; however, certain options granted under such prior plans currently remain outstanding. No stock options were granted to the Named Officers during the year ended December 31, 1999. The following table provides data regarding options exercised during 1999 by the Named Officers as well as the number of shares covered by both exercisable and non-exercisable stock options held by the Named Officers at December 31, 1999. Also reported are -4- the values for "in-the-money" options, which represent the positive spread between the exercise price of an existing option and $3.75, the closing sale price of the Company's Common Stock on the New York Stock Exchange on December 31, 1999.
FISCAL YEAR-END OPTION VALUES Value of Unexercised Number of Unexercised In-the-Money Options at Shares Acquired Options at 12/31/99 12/31/99 NAME on Exercise Value received Exercisable/Unexercisable Exercisable/Unexercisable - ---- --------------- -------------- ------------------------- ------------------------- S. Wilzig Izak -0- -0- 61,912/0 0/0 Steven A. Gelman -0- -0- 5,463/0 0/0
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION The Company does not have a formal Compensation Committee. However, the entire Board of Directors performs the functions of such a Committee by establishing compensation policies. S. Wilzig Izak, the Company's Chief Executive Officer, is a member of the Board of Directors. She has abstained from all votes pertaining to her own compensation. Siggi B. Wilzig, the Company's Senior Consultant and former Chairman and President of the Company, has participated in deliberations of the Board concerning executive officer compensation. Mr. Wilzig has no vote with respect to such matters. At April 20, 2000, the Company had mortgage loans payable to TCNJ in the aggregate principal amount of $24.7 million at a weighted average effective interest rate of approximately 7.46% per annum. At April 20, 2000, the Company also had term loans payable to TCNJ in the aggregate principal amount of $4 million secured by marketable securities; such loans bear interest at the prime lending rate. Siggi B. Wilzig, whose shareholdings of the Company are described under Item 12 herein, is an officer, director and significant shareholder of TCNJ. DIRECTOR COMPENSATION Each director, other than S. Wilzig Izak, receives an annual fee of $11,000. Members of the Executive Committee, other than S. Wilzig Izak, also receive a fee of $4,000 and members of the Audit Committee and Stock Option Committee also receive an annual fee of $2,000. ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT Based on information available to the Company, the Company believes that the following persons held beneficial ownership of more than five percent of the outstanding Common Stock as of April 20, 2000: Name and Address Amount and Nature of of Beneficial Owner Beneficial Ownership Percent of Class ....................... .................... ................ Siggi B. Wilzig 871,183(1) 10.61% 921 Bergen Avenue Jersey City, New Jersey 07306 Dimensional Fund Advisors, Inc. 763,285(2) 9.32% 1299 Ocean Avenue, Suite 650 Santa Monica, CA 90401 - --------------- (1) Includes 22,509 shares of Common Stock that could be obtained by Mr. Wilzig on the exercise of stock options exercisable within 60 days of April 20, 2000. Mr. Wilzig, former Chairman and President of the Company, serves as the Senior Consultant to the Company at a remuneration of $90,000 per year. His duties include financial and personnel matters, purchases and sales and other transactions with respect to the Company's assets. -5- (2) Pursuant to a filing with the Securities and Exchange Commission which reported beneficial ownership as of December 31, 1999, Dimensional Fund Advisors, Inc. ("Dimensional"), a registered investment advisor, disclosed that it is deemed to have beneficial ownership of 763,285 shares of Common Stock, all of which shares are held in portfolios of DFA Investment Dimensions Group Inc., a registered open-end investment company, or in series of the DFA Investment Trust Company, a Delaware business trust, or the DFA Group Trust and DFA Participation Group Trust, investment vehicles for qualified employee benefit plans, all of which Dimensional Fund Advisors Inc. serves as investment manager. Dimensional disclaims beneficial ownership of all such shares. The following table presents information with respect to the shares of the Company's Common Stock beneficially owned as of April 20, 2000 by (i) each of the Company's directors and (ii) each Named Officer who is not a director: Common Stock Beneficially Owned Name Shares Percentage of Class(a) ----------------------- ------------ ---------------------- Dr. Ira F. Braun (d) 19,433 0.23% Milton Donnenberg (d) 19,370 0.23 Eric J. Schmertz, Esq. (c) 20,128 0.24 Dr. William J. Schwartz (d) 144,000((b)) 1.74 Ernest Wachtel (d) 95,401 1.15 W. Martin Willschick(e) 3,062 0.04 S. Wilzig Izak 106,710((c)) 1.29 - --------------- (a) The shares of the Company's Common Stock reflected in this table are owned directly and beneficially, and the holders have sole voting and investment power, except as otherwise noted. (b) Includes 26,813 shares of stock owned by a profit sharing plan, 27,864 shares owned by Dr. Schwartz' wife and 2,953 shares owned by or on behalf of Dr. Schwartz' children. (c) Includes 61,912 shares of stock that could be obtained by S. Wilzig Izak on the exercise of options exercisable within 60 days of April 20, 2000. (d) Includes 7,210 shares of stock that could be obtained by each of these Outside Directors on the exercise of options exercisable within 60 days of April 20, 2000. (e) Includes 1,000 shares of stock that could be obtained by W. Martin Willschick on the exercise of options exercisable within 60 days of April 20, 2000. At April 20, 1999, all directors and current executive officers as a group (seven persons) beneficially owned equity securities as follows including an aggregate of 98,962 shares that could be obtained on the exercise of options exercisable within 60 days of April 20, 2000: Title of Class Amount Beneficially Owned Percent of Class -------------- ------------------------- ---------------- Common Stock 408,104 4.92% ($1.00 par value) -6- ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS See Item 11 -- "Compensation Committee Interlocks and Insider Participation." -7- SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this amendment to its report to be signed on its behalf by the undersigned thereunto duly authorized. WILSHIRE OIL COMPANY OF TEXAS ----------------------------- (Registrant) DIRECTORS: By:/s/ S. Wilzig Izak -------------------------- S. Wilzig Izak, Director By:/s/ William Schwartz, M.D. -------------------------- William Schwartz, M.D., Director By:/s/ Milton Donnenberg -------------------------- Milton Donnenberg, Director By:/s/ Ernest Wachtel -------------------------- Ernest Wachtel, Director OFFICERS: By:/s/ S. Wilzig Izak -------------------------- S. Wilzig Izak Chairman of the Board and Chief Executive Officer (Duly Authorized Officer and Chief Financial Officer) Date: May 9, 2000 -8- -----END PRIVACY-ENHANCED MESSAGE-----